Outpatient Therapies for COVID-19
Hackensack Meridian Health is using Remdesivir at multiple sites across the health network for the treatment of mild to moderate COVID-19 under current scientific guidelines.
Remdesivir for the Treatment of COVID-19
Remdesivir is a three-day outpatient infusion treatment for the treatment of COVID-19 for patients who are not candidates for Paxlovid™. If you have COVID-19, your physician can refer you to an HMH hospital to determine whether you are eligible or would benefit from this treatment. This treatment is currently offered at:
- Hackensack University Medical Center
- JFK University Medical Center
- Jersey Shore University Medical Center
- Ocean University Medical Center